Compare ARRY & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARRY | CTKB |
|---|---|---|
| Founded | 1989 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 433.8M |
| IPO Year | 2020 | 2021 |
| Metric | ARRY | CTKB |
|---|---|---|
| Price | $8.47 | $4.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 4 |
| Target Price | ★ $10.38 | $5.88 |
| AVG Volume (30 Days) | ★ 6.4M | 1.8M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,333,329,000.00 | $196,828,000.00 |
| Revenue This Year | $40.97 | N/A |
| Revenue Next Year | $13.09 | $5.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 35.75 | N/A |
| 52 Week Low | $3.76 | $2.37 |
| 52 Week High | $10.37 | $7.30 |
| Indicator | ARRY | CTKB |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 47.20 |
| Support Level | $7.77 | $4.79 |
| Resistance Level | $8.22 | $5.16 |
| Average True Range (ATR) | 0.51 | 0.24 |
| MACD | 0.18 | -0.11 |
| Stochastic Oscillator | 66.10 | 9.57 |
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.